ClinicalTrials.Veeva

Menu

Diagnostic Accuracy of a Novel Machine Learning Algorithm to Estimate Gestational Age

University of North Carolina (UNC) logo

University of North Carolina (UNC)

Status

Completed

Conditions

Gestational Age
Machine Learning
Pregnancy Related

Study type

Observational

Funder types

Other

Identifiers

NCT05433519
21-3115

Details and patient eligibility

About

This is a prospective cohort study of women enrolled early in pregnancy, with randomization to determine the timing of three follow-up visits in the second and third trimester. At each of these follow-up visits, investigators will assess gestational age with the FAMLI technology and compare that estimate to the known gestational age established early in pregnancy.

Full description

The primary purpose of this research is to assess the diagnostic accuracy of the FAMLI Technology, a novel machine learning-based tool for gestational age assessment that can run on a smart phone or tablet. Study staff will enroll 400 pregnant volunteers prior to 14 completed gestational weeks and obtain accurate "ground truth" gestational age dating with standard ultrasound biometry, using the crown-rump length. These participants will then be asked to return for three follow-up visits, which will include a routine sonogram performed by a trained sonographer and the collection of a set of blind sweep cineloop videos using a low-cost, battery-operated device. The research will be conducted in Chapel Hill, North Carolina (at the University of North Carolina Hospital and/or sites associated with UNC OBGYN) and in Lusaka, Zambia (at the University Teaching Hospital or Kamwala District Health Centre). Approximately equal numbers of participants will be enrolled from each country.

Enrollment

400 patients

Sex

Female

Ages

18 to 59 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age or older
  • viable intrauterine pregnancy at less than 14 0/7 weeks of gestation
  • ability and willingness to provide written informed consent
  • intent to remain in current geographical area of residence for the duration of study
  • willingness to adhere to study procedures

Exclusion criteria

  • maternal body mass index = 40 kg/m^2
  • multiple gestation (i.e., twins or higher order)
  • major fetal malformation or anomaly
  • any other condition (social or medical) that, in the opinion of the study staff, would make study participation unsafe or complicate data interpretation.

Trial design

400 participants in 1 patient group

Pregnant Women
Description:
Pregnant women with gestational age established at less than 14 weeks of gestation

Trial documents
2

Trial contacts and locations

2

Loading...

Central trial contact

Joan Price, MD; Bellington Vwalika, MMed, MSC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems